English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The study deals with the estimation of the metabolic activity of neutrophils measured with a chemi luminescence assay in children with type I diabetes depending on the disease duration, compared to the control group. The study involved 87 children with type I diabetes aged 4 to 21 years (52 girls, 35 boys). Patients were divided into four subgroups depending on the disease duration: subgroup I ‐ the disease duration up to 12 months (35 children), subgroup II ‐ the disease duration up to 5 years (28 children), subgroup III ‐ the disease duration up to 10 years (12 children), and subgroup IV ‐ the disease dura tion over 10 years (12 children). The control group was composed of 23 persons ‐ healthy volunteers aged 20 to 25 years (mean age 23 years). The metabolic activity of neutrophils was determined in a lumi nol-dependent chemiluminescence assay. The spontaneous and stimulated chemiluminescence of neutrophils (fMLP, opsonised Zymosan, PMA) was tested on a 96-well microplate (LB96P-WMP). The chemiluminescence assay was conducted using a luminometer (MicroLumat LB 96P of E&G BARTHOLD). The results have been written in RLU units (Relative Light Units/s) as the maximum val ue of chemiluminescence (CLmax). The test showed statistically significantly lower values of sponta neous and stimulated neutrophil chemiluminescence in all subgroups, compared to the control group. The lowest levels of neutrophil CL were in subgroup III (neutrophils stimulated with fMLP and PMA) and also in children with newly detected diabetes (Zymosan-stimulated neutrophils).

central-european journal of immunology/central european journal of immunology

Clinical immunology The metabolic activity of neutrophils measured with a chemiluminescence assay in young patients with type 1 diabetes depending on the disease duration